The Global Neurovascular Devices Market Size is projected to grow at a CAGR of 8.40% during the forecast period from 2026 to 2034 | DelveInsight

The Neurovascular Devices market is estimated at USD 3,904.74 million in 2025 and is projected to reach USD 8,044.66 million by 2034. Growth is anchored in the rising prevalence of stroke, cerebral aneurysms, and other cerebrovascular diseases, alongside continuous technological advancement in minimally invasive devices.

DelveInsight's Neurovascular Devices Market Insights Report 2034 provides the current and forecast market analysis, individual leading Neurovascular Devices companies' market shares, challenges, Neurovascular Devices Market Drivers, barriers, trends, and key market Neurovascular Devices companies in the market.

To read more about the latest highlights related to the Neurovascular Devices Market:
https://www.delveinsight.com/report-store/neurovascular-devices-interventional-neurology-market?utm_source=openpr&utm_medium=pr&utm_campaign=kkpr

Key Takeaways from the Neurovascular Devices Market Report

- In April 2025, Terumo Neuro's Dual-Layer Micromesh Carotid Stent System received FDA Premarket Approval (PMA), the first of its kind in the U.S., targeting carotid stenosis with vessel diameters from 3.5 mm to 9 mm. Strategic significance: Offers a significant new option for patients at higher risk following endarterectomy.
- In February 2025, Stryker Corporation acquired Inari Medical and Boston Scientific's Neurovascular business. Strategic significance: Significantly expands Stryker's Neurovascular device portfolio and market position.
- In October 2024, Contego Medical received FDA premarket approval (PMA) for the Neuroguard IEP® System, featuring the company's clinically proven Integrated Embolic ProtectionTM (IEP) technology. Strategic significance: Highlights ongoing innovation and expansion in the neuroprotection devices segment.
- The global Neurovascular Devices market is growing at a CAGR of 8.40% during the forecast period from 2026 to 2034.
- The principal drivers are the increasing prevalence of neurological disorders such as stroke, brain aneurysms, and arteriovenous malformations; increasing technological advancements including next-generation stent retrievers, flow diverters, and AI-enabled imaging systems; and a rise in product development activities among key market players.
- The leading Neurovascular Devices Companies include Johnson & Johnson Services Inc., Medtronic, Stryker, Terumo Corporation, Penumbra, Inc., Microport Scientific Corporation, Kaneka Corporation, Integer Holdings Corporation, phenox GmbH, Perflow Medical Ltd., Balt, Rapid Medical, ASAHI INTECC CO., LTD., Acandis GmbH, and Cerus Endovascular Inc., among others.

To know more about why North America is leading the market growth in the Neurovascular Devices Market, get a snapshot:
https://www.delveinsight.com/report-store/neurovascular-devices-interventional-neurology-market?utm_source=openpr&utm_medium=pr&utm_campaign=kkpr

Neurovascular Devices Overview

Neurovascular devices are specialized medical devices used to diagnose and treat disorders affecting the blood vessels of the brain and spinal cord. These devices are primarily used in minimally invasive procedures to manage conditions such as stroke, cerebral aneurysms, arteriovenous malformations (AVMs), and other cerebrovascular diseases. Common examples include stent retrievers, flow diverters, embolization coils, thrombectomy devices, and microcatheters, which help restore blood flow, prevent vessel rupture, or block abnormal blood vessels in the brain.

Neurovascular Devices Market Key Growth Drivers

- The increasing prevalence of neurological disorders such as stroke, brain aneurysms, and arteriovenous malformations, driven by aging populations, sedentary lifestyles, and risk factors like hypertension and diabetes, is creating higher demand for advanced diagnostic and treatment solutions.
- Globally, more than 3.5 million new cases of intracerebral hemorrhagic stroke occur each year, representing over 28.5% of all stroke incidents, while approximately 1.3 million new subarachnoid hemorrhagic strokes are reported annually, sustaining strong demand for neurovascular intervention devices.
- Increasing technological advancements, including next-generation stent retrievers, flow diverters, embolic coils, and AI-enabled imaging systems, are enhancing precision, safety, and success rates of minimally invasive procedures, encouraging broader clinical adoption.
- Rising product development activity among key market players is expanding the availability of advanced, safer treatment options, exemplified by Penumbra's June 2024 CE Mark and European launch of its BMXTM81 and BMXTM96 neuro access technologies.
- Growing awareness about early diagnosis and improved healthcare infrastructure are accelerating adoption of neurovascular devices across hospitals and specialty neurology centers, supported by innovations such as Johnson & Johnson's April 2024 launch of the CEREGLIDETM 71 Aspiration Catheter featuring TruCourseTM technology.
- The combination of high patient burden, clinical need for effective treatment, and continuous innovation in device technology is creating a strong growth trajectory for the market through 2034.

Get a sneak peek at the Neurovascular Devices Market Dynamics:
https://www.delveinsight.com/report-store/neurovascular-devices-interventional-neurology-market?utm_source=openpr&utm_medium=pr&utm_campaign=kkpr

Neurovascular Devices Market Segment Analysis

The Neurovascular Devices Market by Product Type (Cerebral Embolization and Aneurysm Coiling Devices [Embolic Coils, Flow Diversion Devices, and Liquid Embolic Agents], Cerebral Balloon Angioplasty and Stenting Systems [Carotid Artery Stents and Embolic Protection Systems], Neurothrombectomy Devices [Clot Retrievers, Suction Devices, and Vascular Snare], and Support Devices [Micro Catheters and Micro Guidewires]), Application (Stroke, Cerebral Aneurysm, Carotid Artery Stenosis, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

By Product Type: Within the cerebral balloon angioplasty and stenting systems category, the Carotid Artery Stents segment is projected to dominate in 2025, capturing approximately 65% of the market share. Carotid artery stents offer less invasive, highly effective treatment for carotid artery disease, a leading cause of ischemic stroke, with technological innovations such as dual-layer micromesh and integrated embolic protection enhancing safety and long-term outcomes.

By Application: The Stroke category is projected to account for the largest share at 55% in 2025, driven by the high prevalence of ischemic strokes, with the U.S. recording nearly 754,000 diagnosed cases of acute ischemic stroke in 2023. Minimally invasive thrombectomy procedures using stent retrievers, aspiration catheters, and embolic protection systems have become the standard of care for eligible patients.

By End-User: Hospitals dominate the market, driven by investments in advanced imaging systems, catheterization labs, and specialized stroke care units, alongside a focus on early diagnosis and rapid intervention.

By Geography: North America is expected to account for the highest share at 38% in 2025, due to the high prevalence of stroke and other neurovascular disorders, established healthcare infrastructure, and supportive reimbursement policies. Asia-Pacific is emerging as a major growth driver, propelled by a rapidly rising patient pool and growing awareness of minimally invasive procedures across the region.

Which MedTech key players in the Neurovascular Devices Market are set to emerge as the trendsetter, explore:
https://www.delveinsight.com/report-store/neurovascular-devices-interventional-neurology-market?utm_source=openpr&utm_medium=pr&utm_campaign=kkpr

Neurovascular Devices Market Competitive Landscape

The Neurovascular Devices market is moderately consolidated, with a handful of global leaders holding substantial market share while regional players and emerging startups steadily gain traction. Major companies such as Medtronic, Stryker Corporation, Johnson & Johnson, Penumbra Inc., and Terumo Corporation dominate the market with comprehensive portfolios of neurovascular stents, coils, thrombectomy devices, and embolization systems, supported by advanced technologies, extensive global distribution networks, and strategic acquisitions such as Stryker's acquisition of Inari Medical. Emerging players in Asia-Pacific regions like China, Japan, and India are intensifying competition through cost-effective and localized solutions, gradually reshaping the competitive environment.

Neurovascular Devices Companies

Johnson & Johnson Services Inc., Medtronic, Stryker, Terumo Corporation, Penumbra, Inc., Microport Scientific Corporation, Kaneka Corporation, Integer Holdings Corporation, phenox GmbH, Perflow Medical Ltd., Balt, Rapid Medical, ASAHI INTECC CO., LTD., Acandis GmbH, Cerus Endovascular Inc., and others.

Neurovascular Devices Market Restraints

Despite strong momentum, the Neurovascular Devices market faces material constraints. A growing number of product recalls, particularly those related to safety concerns, device malfunctions, or quality control issues, can result in financial losses for manufacturers and damage brand reputation, reducing physician and patient confidence in advanced neurovascular technologies. Additionally, the stringent regulatory approval processes imposed by authorities such as the FDA and EMA significantly increase development timelines and costs, delaying product launches and limiting the entry of new players into the market.

Interested in knowing the Neurovascular Devices Market by 2034? Click to get a snapshot of the Neurovascular Devices Market Trends:
https://www.delveinsight.com/report-store/neurovascular-devices-interventional-neurology-market?utm_source=openpr&utm_medium=pr&utm_campaign=kkpr

Scope of the Neurovascular Devices Market Report

- Coverage: Global
- Study Period: 2023 to 2034
- Forecast Period: 2026 to 2034
- Neurovascular Devices Companies: Johnson & Johnson Services Inc., Medtronic, Stryker, Terumo Corporation, Penumbra, Inc., Microport Scientific Corporation, Kaneka Corporation, Integer Holdings Corporation, phenox GmbH, Perflow Medical Ltd., Balt, Rapid Medical, ASAHI INTECC CO., LTD., Acandis GmbH, Cerus Endovascular Inc., and others.
- Neurovascular Devices Market Restraints and Regulatory Analysis
- Neurovascular Devices Porter Five Forces Analysis and Market Assessment

Explore more information of the Neurovascular Devices Market Insights:
https://www.delveinsight.com/report-store/neurovascular-devices-interventional-neurology-market?utm_source=openpr&utm_medium=pr&utm_campaign=kkpr

Table of Contents

1. Neurovascular Devices Market Report Introduction
2. Neurovascular Devices Market Executive Summary
3. Neurovascular Devices Market Key Factors Analysis
4. Impact Analysis
5. Regulatory Analysis
6. Neurovascular Devices Market Porter's Five Forces Analysis
7. Neurovascular Devices Market Assessment
8. Competitive Landscape
9. Startup Funding & Investment Trends
10. Neurovascular Devices Market Company and Product Profiles
11. Neurovascular Devices KOL Views
12. Project Approach
13. About DelveInsight
14. Disclaimer & Contact Us

Company Name: DelveInsight Business Research LLP
Contact Person: Kanishk Kumar
Email: info@delveinsight.com
Phone: 9650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

This release was published on openPR.